Ryan Gentzler, MD, MS
@ryangentzler.bsky.social
Thoracic medical oncologist and Associate Professor at UVA Comprehensive Cancer Center, Charlottesville, VA. Editor, JCO Meeting Abstracts. #LCSM #Oncsky
⭐️CRS and ICANS manageable with appropriate monitoring & interventions. Short time to resolution.
Full poster here:
Full poster here:
February 23, 2025 at 12:53 PM
⭐️CRS and ICANS manageable with appropriate monitoring & interventions. Short time to resolution.
Full poster here:
Full poster here:
National rate is 16%. Varies by state and regions within states. State by state data here:
www.lung.org/research/sta...
www.lung.org/research/sta...
State of Lung Cancer
Examining lung cancer incidence, survival, stage at diagnosis, surgical treatment, lack of treatment, and screening, this report finds states must do more to protect their residents from lung cancer.
www.lung.org
November 26, 2024 at 11:12 AM
National rate is 16%. Varies by state and regions within states. State by state data here:
www.lung.org/research/sta...
www.lung.org/research/sta...
Just gave my 1st line lecture last week. I also briefly cover ECOG 1594, Scagliotti et al. Cis/Pem vs. Cis/Gem, and PARAMOUNT, so they understand the data supporting the chemo backbone of current regimens and show them how far we've come. But I keep cutting these slides back each year to make room!
November 25, 2024 at 3:04 AM
Just gave my 1st line lecture last week. I also briefly cover ECOG 1594, Scagliotti et al. Cis/Pem vs. Cis/Gem, and PARAMOUNT, so they understand the data supporting the chemo backbone of current regimens and show them how far we've come. But I keep cutting these slides back each year to make room!